The CCL5/CCR5 axis contributes to the perineural invasion of human salivary adenoid cystic carcinoma

Liebig, 2009, Perineural invasion in cancer: a review of the literature, Cancer, 115, 3379, 10.1002/cncr.24396

Barrett, 2009, Perineural invasion in adenoid cystic carcinoma of the salivary glands: a valid prognostic indicator?, Oral Oncol, 45, 936, 10.1016/j.oraloncology.2009.07.001

Johnston, 2012, Perineural invasion and spread in head and neck cancer, Expert Rev Anticancer Ther, 12, 359, 10.1586/era.12.9

Poeschl, 2010, Perineural invasion: correlation with aggressive phenotype and independent prognostic variable in both colon and rectum cancer, J Clin Oncol, 28, e358, 10.1200/JCO.2009.27.3581

Fromont, 2012, Biological significance of perineural invasion (PNI) in prostate cancer, Prostate, 72, 542, 10.1002/pros.21456

Sakurai, 1990, Contraction induced by Clostridium perfringens alpha toxin in the isolated rat ileum, Toxicon, 28, 411, 10.1016/0041-0101(90)90079-M

Cavel, 2012, Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor, Cancer Res, 72, 5733, 10.1158/0008-5472.CAN-12-0764

Bapat, 2011, Perineural invasion and associated pain in pancreatic cancer, Nat Rev Cancer, 11, 695, 10.1038/nrc3131

Wang, 2012, CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma, PLoS One, 7, e35101, 10.1371/journal.pone.0035101

McIver, 2013, The chemokine CXCL12 and its receptor CXCR4 are implicated in human seminoma metastasis, Andrology, 1, 517, 10.1111/j.2047-2927.2013.00081.x

Zhu, 2012, The role of CXC chemokines and their receptors in the progression and treatment of tumors, J Mol Histol, 43, 699, 10.1007/s10735-012-9435-x

Lv, 2013, CCL5 as a potential immunotherapeutic target in triple-negative breast cancer, Cell Mol Immunol, 10, 303, 10.1038/cmi.2012.69

Bolin, 1998, Primary sensory neurons migrate in response to the chemokine RANTES, J Neuroimmunol, 81, 49, 10.1016/S0165-5728(97)00158-6

Vaday, 2006, Expression of CCL5 (RANTES) and CCR5 in prostate cancer, Prostate, 66, 124, 10.1002/pros.20306

Borczuk, 2008, Lung adenocarcinoma invasion in TGFβRII-deficient cells is mediated by CCL5/RANTES, Oncogene, 27, 557, 10.1038/sj.onc.1210662

Zhang, 2009, Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24− phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression, Oncol Rep, 21, 1113

Swamydas, 2013, Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases, Cell Adh Migr, 7, 315, 10.4161/cam.25138

Pinilla, 2009, Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion, Cancer Lett, 284, 80, 10.1016/j.canlet.2009.04.013

Velasco-Velázquez, 2012, CCR5 antagonist blocks metastasis of basal breast cancer cells, Cancer Res, 72, 3839, 10.1158/0008-5472.CAN-11-3917

Demir, 2012, Nerve-cancer interactions in the stromal biology of pancreatic cancer, Front Physiol, 3, 97, 10.3389/fphys.2012.00097

Li, 2008, Clinical analysis of salivary gland tumor cases in West China in past 50 years, Oral Oncol, 44, 187, 10.1016/j.oraloncology.2007.01.016

Yang, 2010, Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients’ prognosis, Oral Oncol, 46, 755, 10.1016/j.oraloncology.2010.08.008

Sukhanova, 2013, Mechanisms of [Ca2+]i elevation following P2X receptor activation in the guinea-pig small mesenteric artery myocytes, Pharmacol Rep, 65, 152, 10.1016/S1734-1140(13)70973-3

Yang, 2012, EMMPRIN contributes to the in vitro invasion of human salivary adenoid cystic carcinoma cells, Oncol Rep, 27, 1123, 10.3892/or.2011.1606

Yang, 2012, EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo, Cancer Biol Ther, 13, 85, 10.4161/cbt.13.2.18455

Bravo-Cordero, 2012, Directed cell invasion and migration during metastasis, Curr Opin Cell Biol, 24, 277, 10.1016/j.ceb.2011.12.004

Olson, 2009, The actin cytoskeleton in cancer cell motility, Clin Exp Metastasis, 26, 273, 10.1007/s10585-008-9174-2

Detchokul, 2013, Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies, Br J Pharmacol

Dai, 2007, Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach, Hum Pathol, 38, 299, 10.1016/j.humpath.2006.08.002

Swanson, 2007, MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion, Cancer Res, 67, 10222, 10.1158/0008-5472.CAN-06-2483

Sayana, 2009, Maraviroc: a new CCR5 antagonist, Expert Rev Anti Infect Ther, 7, 9, 10.1586/14787210.7.1.9

Kast, 2010, Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug, J Clin Pharm Ther, 35, 657, 10.1111/j.1365-2710.2009.01148.x